Q4 EPS Estimates for BIOX Decreased by Analyst

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Analysts at Brookline Capital Management reduced their Q4 2025 earnings per share estimates for Bioceres Crop Solutions in a research report issued to clients and investors on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings of $0.09 per share for the quarter, down from their prior estimate of $0.13. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share.

Several other equities research analysts have also weighed in on the company. Roth Mkm lowered their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Lake Street Capital lowered their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a report on Wednesday. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Finally, Oppenheimer reduced their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of “Buy” and an average price target of $12.13.

Bioceres Crop Solutions Stock Performance

NASDAQ BIOX opened at $6.17 on Thursday. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The stock has a market cap of $387.78 million, a P/E ratio of 321.16 and a beta of 0.49. The company’s 50-day simple moving average is $7.58 and its 200 day simple moving average is $9.80.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period last year, the firm earned ($0.07) EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in BIOX. Oppenheimer & Co. Inc. acquired a new stake in Bioceres Crop Solutions in the 1st quarter valued at about $139,000. Lazard Asset Management LLC acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at approximately $212,000. Stifel Financial Corp raised its position in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the last quarter. Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the 2nd quarter worth $448,000. Finally, Sumitomo Mitsui Trust Holdings Inc. acquired a new position in Bioceres Crop Solutions during the 2nd quarter worth $472,000. 17.68% of the stock is owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.